TOX3 clinical implications and its role in tumour development and the invasion have been shown in the risk of breast cancer (Chalabi et al., 2008[6]; Mahfoudh et al., 2012[21]; Tajbakhsh et al., 2017[30], 2019[31]). The gene discussed is TOX3; the disease is breast cancer.